Table 2:
First author | Cell retention |
Fibre organization and contacts formed |
Infarct size, scar and wall changes |
|||
---|---|---|---|---|---|---|
Omentum- supported bioengineered tissue | Comparison group: bioengineered tissue no omentum support | Omentum- supported bioengineered tissue | Comparison group: bioengineered tissue no omentum support | Omentum- supported bioengineered tissue | Comparison group: bioengineered tissue no omentum support | |
Kainuma et al. [20] | Engrafted area remaining with time | Collagen content | ||||
|
|
8% | 13% | |||
Day 28 = 0.15 mm2 | Day 28 = 0.05 mm2 | LV wall thickness | ||||
912 µm | 688 µm | |||||
Myocyte size | ||||||
16 µm | 20 µm | |||||
Key findings | ∼3–4× increased area of grafted cells remained in situ with omentum supporta | Scar collagen attenuation, less thick LV wall, reduced hypertrophy with omentum support | ||||
Kawamura et al. [22] | Cell % survival rate | Myosin heavy chain/myosin light chain-2 positive (striated filaments) | ||||
|
|
Present | Not reported | |||
Key findings | Improved grafted cell survival with omentum supporta | Well-organized sarcomere structure in cells with omentum support (not compared to control) | ||||
Lilyanna et al. [23] | Bioluminescence photon emission flux of labelled live donor cells (photons/s) | Scar size (LV cross sectional area % containing fibrosis) | ||||
|
|
34.7% | 35.7% | |||
Key findings | Donor cell attrition rate in vivo over time comparable with or without omentum support | Minimal difference in scar with or without omentum support | ||||
Shudo et al. [24] | Infarct area | |||||
∼6% | ∼11% | |||||
Key findings | Infarct size (infarcted LV/total LV estimated by computer-based planimetry of Masson trichrome-staining) reduced with omentum supporta | |||||
Suzuki et al. [25] | Cardiomyocyte survival | |||||
46% | 31% | |||||
Cell sheet thickness | ||||||
120 μm | 70 μm | |||||
Key findings | Improved graft survival with omentum support | |||||
Takaba et al. [26] | Dynamic % wall thickening of infarct region | |||||
49% | 41% | |||||
Key findings | % fractional wall thickening (assessed by cine MRI for quantitative wall motion) increased with omentum support | |||||
Ueyama et al. [27] | Infarct size | |||||
10% | 16% | |||||
LV circumference | ||||||
48 mm | 56 mm | |||||
Scar circumference | ||||||
16 mm | 24 mm | |||||
Infarct area wall thickness | ||||||
2.5 mm (ns) | 2.0 mm (ns) | |||||
Key findings | Reduced infarct size, dilatation and scar. No significant difference in wall thickness | |||||
Zhang et al. [29] | Atrial tissue patch graft presence after 4 weeks | Scar thickness | ||||
In situ | Not seen | ∼0.4 mm (ns) | ∼0.35 mm (ns) | |||
Infarct size | ||||||
∼38% (ns) | ∼39% (ns) | |||||
Key findings | Troponin-stained graft survived with omentum support but did not without omentum support | No significant difference in scar thickness or infarct size with or without omentum supporta | ||||
Zhou et al. [30] | Quantification PCR of grafted cellsb | Connective protein Cx-43 expressionc | Collagen (scar) density | |||
|
|
0.23 units | 0.19 units | 16% | 26% | |
Key findings | Cell survival rate in vivo over time improved with omentum support | Higher levels of Cx-43 suggested enhanced structural coupling of transplanted cells to host myocardium. Sham group (baseline) level = 0.31; MI with no treatment group level = 0.11 | Reduced % fibrillar collagen in the infarction zone (semiquantitatively measured by picrosirius red staining under polarized light microscopy) |
Numerical data extrapolated from graphical figure.
Units expressed as ratio of optical density under UV light compared to reference sample at the same time.
Cx-43 protein expression determined by western blot. Units expressed as ratio to the level of β-actin which was run on all blots.
Cx-43: connexin-43; LV: left ventricle; MI: myocardial infarction; MRI: magnetic resonance imaging; ns: result not statistically significant; PCR: polymerase chain reaction; UV: ultra-violet.